Related by context. All words. (Click for frequent words.) 73 colorectal cancer 71 prostate cancer CaP 71 HNSCC 70 endometrial cancers 69 cancers 68 HER2 overexpression 68 epithelial ovarian cancer 68 bowel cancers 68 bladder cancers 68 nonmelanoma skin cancer 67 oesophageal adenocarcinoma 67 malignant pleural mesothelioma 67 precursor lesions 67 AAT deficiency 67 colorectal neoplasia 67 chlamydial infection 67 BRCA mutations 66 neoplasias 66 ADPKD 66 thyroid nodules 66 rectal cancers 66 colorectal cancers 66 pancreatic adenocarcinoma 66 hepatocellular carcinoma HCC 66 MGUS 66 skeletal metastases 66 nonmelanoma skin cancers 66 testicular cancers 66 endometrial hyperplasia 66 PCa 66 CIN3 66 gastric cancers 66 lobular carcinoma 66 gastric carcinoma 66 prostate cancers 65 Adenomas 65 node metastases 65 hepatocellular carcinoma 65 CIN2 + 65 prostate adenocarcinoma 65 T1DM 65 nasopharyngeal carcinoma 65 seminoma 65 advanced adenoma 65 ductal cancer 65 colorectal lung 65 renal cell carcinomas 65 adenomatous polyps 65 thromboembolic disease 65 epithelial tumors 65 colorectal adenomas 65 NAFLD 65 diabetes mellitus DM 65 ovarian cancers 65 malignant lymphoma 65 malignancies 65 colorectal adenoma 65 cervical carcinoma 65 Hepatocellular Carcinoma HCC 65 urothelial carcinoma 65 nonalcoholic steatohepatitis NASH 65 cutaneous melanoma 65 systemic lupus erythematosus SLE 65 testicular germ cell 65 prostate cancer PCa 65 gastric adenocarcinoma 65 leiomyomas 65 breast carcinoma 64 Helicobacter pylori infection 64 serous ovarian cancer 64 squamous cell lung cancer 64 urolithiasis 64 breast cancers 64 adjuvant therapies 64 colorectal carcinoma 64 Malignant Melanoma 64 advanced adenomas 64 colorectal neoplasms 64 gastrointestinal cancers 64 hepatocellular carcinomas 64 candidemia 64 atypical hyperplasia 64 grade cervical intraepithelial 64 chronic periodontitis 64 G6PD deficiency 64 invasive carcinoma 64 gastric cancer 64 advanced neoplasia 64 cervical lesions 64 esophageal squamous cell carcinoma 64 nonmetastatic 64 ASCUS 64 colorectal polyps 64 thyroid dysfunction 64 endometrial carcinoma 64 hereditary breast cancer 64 grade cervical dysplasia 64 hepatocellular cancer 64 colon cancers 64 p# biomarker 64 Chronic lymphocytic leukemia 64 pharyngeal cancer 64 AA Amyloidosis 63 atypical ductal hyperplasia 63 breast endometrial 63 PCNSL 63 ovarian carcinoma 63 basal cell carcinoma BCC 63 neoplasia 63 H. pylori infection 63 KRAS mutation 63 nodal metastasis 63 non squamous NSCLC 63 proliferative diabetic retinopathy 63 precancer 63 Renal Cell Carcinoma RCC 63 GISTs 63 pancreatic lung 63 PAOD 63 hereditary predisposition 63 invasive prenatal 63 Radical prostatectomy 63 ductal breast cancer 63 antigen PSA 63 carotid stenosis 63 CP CPPS 63 subclinical hyperthyroidism 63 myeloproliferative neoplasms 63 ovarian cancer 63 CMV infection 63 systemic scleroderma 63 grade gliomas 63 breast carcinomas 63 pancreatic cancers 63 leukaemias 63 nonsmall cell lung cancer 63 neoplasm 63 leukemia ALL 63 pulmonary metastases 63 malignant neoplasms 63 postoperative delirium 63 operable breast cancer 63 histologic subtype 63 CMV disease 63 Sjögren syndrome 63 neuroendocrine tumors 63 lobular breast cancer 63 familial pancreatic cancer 63 KRAS status 63 dysglycemia 63 metastatic gastric 63 peritoneal cancer 63 bronchogenic carcinoma 63 prostate cancer 63 nonalcoholic steatohepatitis 63 metastatic colorectal 62 hepatorenal syndrome 62 metastatic neuroendocrine tumors 62 prostate pancreatic 62 colorectal breast 62 carcinoid 62 colorectal tumors 62 premalignant lesions 62 Sentinel node biopsy 62 invasive cervical cancer 62 precancerous cervical 62 chronic HBV 62 Hodgkin lymphoma HL 62 invasive candidiasis 62 sCJD 62 precancerous cervical lesions 62 gynecologic malignancy 62 oropharyngeal cancer 62 metastatic prostate cancer 62 situ LCIS 62 Prostatitis 62 EUS FNA 62 juvenile idiopathic arthritis 62 Adjuvant chemotherapy 62 cervical intraepithelial neoplasia 62 HGPIN 62 endometrial cancer 62 HER2 positive cancers 62 uterine cancers 62 squamous cell carcinoma SCC 62 postoperative pulmonary 62 Haptoglobin 62 postoperative AF 62 lobular cancer 62 latent tuberculosis infection 62 CYT# potent vascular disrupting 62 Endometrial cancer 62 renal tumors 62 esophageal cancers 62 ovarian lung 62 differentiated thyroid 62 malignant polyps 62 Barrett esophagus 62 perioperative morbidity 62 Genetic variants 62 adrenocortical cancer 62 metastatic lung cancer 62 diffuse gastric 62 elevated triglyceride levels 62 LQTS 62 myelofibrosis polycythemia vera 62 HCV infections 62 distant metastasis 62 HNPCC 62 carcinomas 62 bacteraemia 62 SLNB 62 Evoltra ® 62 Chronic Heart Failure 62 uveal melanoma 62 germline mutations 62 HBV infection 62 secondary hyperparathyroidism 62 osteosarcomas 62 chronic prostatitis 62 renal carcinoma 62 T2DM 62 genital herpes infections 62 thrombophilia 62 cytomegalovirus infection 62 gynecological cancers 62 HER2 positive breast cancer 62 carcinoid tumors 62 MALT lymphoma 62 LVNC 62 follicular lymphoma FL 62 Prostate Specific Antigen PSA 62 biliary tract cancer 62 colon rectal cancer 62 AGHD 62 lung adenocarcinoma 62 hematopoietic cancers 62 acute leukemias 62 BRCA mutation carriers 62 Flexi Scope 62 Rectal cancer 62 smoldering myeloma 62 pancreatic NET 61 Heavy menstrual bleeding 61 basal cell nevus syndrome 61 gastrointestinal stromal tumors GISTs 61 microalbuminuria 61 urothelial cancer 61 CaP 61 Cardiotoxicity 61 gynecologic cancers 61 Nexavar sorafenib 61 juvenile idiopathic arthritis JIA 61 bone metastasis 61 pre cancerous polyps 61 soft tissue sarcomas 61 pituitary adenomas 61 detecting colorectal cancer 61 polycystic ovary syndrome PCOS 61 HIV HCV coinfected 61 metastatic malignant 61 acute myelogenous leukemia AML 61 SHPT 61 BRCA2 mutation carriers 61 cancerdefine 61 ductal adenocarcinoma 61 ovarian cervical 61 malignant neoplasm 61 cholangiocarcinoma 61 colorectal 61 gallstone disease 61 tumor histology 61 malignant tumors 61 colorectal cancer incidence 61 CIN3 + 61 bladder cancer 61 squamous cell carcinomas 61 Recurrences 61 choriocarcinoma 61 HCV infection 61 neuroendocrine cancers 61 hematological disorders 61 atrophic gastritis 61 Metastases 61 hepatic cirrhosis 61 chlamydia infection 61 deCODE BreastCancer TM 61 basal cell carcinomas 61 postoperative atrial fibrillation 61 Squamous 61 chronic HBV infection 61 Acute Myeloid Leukaemia AML 61 systemic fungal infections 61 prostate TURP 61 allogeneic HSCT 61 proliferative retinopathy 61 intestinal metaplasia 61 prostate carcinoma 61 adenocarcinomas 61 gynecological malignancies 61 atherothrombotic disease 61 NSCLC 61 renal cell carcinoma 61 GnRH agonists 61 recurrent miscarriage 61 prognostic markers 61 Acute myeloid leukemia 61 untreated celiac disease 61 subclinical hypothyroidism 61 Invasive Breast Cancer 61 liver metastasis 61 R0 resection 61 ALCL 61 Thyroid nodules 61 venous blood clots 61 superficial bladder cancer 61 CHD mortality 61 adenomatous 61 colonic polyps 61 invasive lobular 61 mesotheliomas 61 Prostate Cancer ERSPC 61 Lung transplantation 61 adenoma 61 testicular tumors 61 bacterial vaginosis BV 61 immunocompetent 61 esophageal carcinoma 61 neoplasms 61 invasive aspergillosis 61 cervical neoplasia 61 chemoprevention trials 61 hamartomas 61 cutaneous squamous cell carcinoma 61 upper gastrointestinal bleeding 60 overt nephropathy 60 breast cancer subtypes 60 disease NAFLD 60 simplex virus 60 LTBI 60 EGFR mutation 60 kidney urologic 60 Prostate specific antigen 60 melanoma 60 metastases 60 microsatellite instability 60 prognostic variables 60 osteoporotic vertebral fractures 60 VUR 60 Benign Prostatic Hyperplasia BPH 60 gastric cardia 60 asymptomatic carotid stenosis 60 eosinophilic pneumonia 60 clinically localized prostate 60 epithelial ovarian 60 GIST tumors 60 lupus nephritis 60 HSCT 60 pCR 60 lung cancers 60 Fludara ® 60 renal artery stenosis 60 urologic diseases 60 Cholangiocarcinoma 60 Epidemiologic studies 60 fetal aneuploidy 60 colon cancer 60 Gastric cancer 60 Li Fraumeni 60 anal cancers 60 grade glioma 60 Waldenstrom macroglobulinemia 60 androgenetic alopecia 60 Chronic pancreatitis 60 curable cancers 60 periodontitis 60 ependymoma 60 somatic mutation 60 bladder tumors 60 liver fibrosis 60 breast cancer recurrence 60 Digital Mammographic Imaging 60 de ath 60 distant metastases 60 BRCA2 mutations 60 Acute myeloid leukemia AML 60 ovarian pancreatic 60 cell carcinomas 60 microdeletions 60 esophageal adenocarcinoma 60 prostate specific 60 bronchopulmonary dysplasia BPD 60 haematopoietic 60 chronic eosinophilic leukemia 60 rectal cancer 60 bicuspid aortic valves 60 grade squamous intraepithelial 60 prognostic indicators 60 hemodialysis patients 60 mRCC 60 neurological manifestations 60 cardiovascular disease hypertension 60 metastatic renal cell carcinoma 60 invasive breast cancer 60 metachronous 60 lymph node metastases 60 urine dipstick 60 Stomach cancer 60 myelodysplastic syndrome MDS 60 bladder carcinoma 60 alcoholic hepatitis 60 benign neoplasms 60 Aortic stenosis 60 Non Alcoholic Fatty 60 relapsing remitting MS RRMS 60 nodal metastases 60 Prostate Specific Antigen 60 serum folate concentrations 60 HeFH 60 paragangliomas 60 adjuvant radiotherapy 60 postmenopausal breast cancer 60 Candida infection 60 immunochemical fecal occult 60 Plasmodium falciparum malaria 60 carotid plaques 60 invasive ductal 60 neoadjuvant therapy 60 gestational diabetes mellitus 60 BRCA1 mutations 60 Myelodysplastic syndromes MDS 60 recurrent colorectal cancer 60 Nilotinib 60 HbF 60 MYH9 gene 60 ductal carcinomas 60 ovarian tumors 60 PROLARIS 60 INTERHEART 60 HIVAN 60 pelvic lymphadenectomy 60 Colorectal cancer screening 60 recurrent ovarian cancer 60 lymphoma subtypes 60 HER2 expression 60 ovarian breast 60 medullary thyroid cancer 60 cerebral infarction 60 pleural mesothelioma 60 precancers 60 lymphangioleiomyomatosis LAM 60 gastrointestinal stromal tumors GIST 60 Papillary 60 lung carcinomas 60 OSAHS 60 imatinib resistance 60 polyp recurrence 60 chlamydial infections 60 chronic lymphocytic leukemia CLL 60 hepatic fibrosis 60 DVT PE 60 hereditary hemochromatosis 60 MRSA colonization 60 ABCB1 60 colorectal carcinomas 60 subependymal giant cell 60 recurrent NSCLC 60 primary hyperparathyroidism 60 aneuploidies 60 Alzheimer Disease AD 60 postoperative morbidity 60 Leukemias 60 carcinoma 60 prostate abnormalities 60 T1a 60 renal scarring 60 papillary renal cell carcinoma 60 folate deficiency 60 peritoneal carcinomatosis 60 erythema nodosum 60 Androgen deprivation therapy 60 malignant lesions 60 urothelial bladder cancer 60 Oesophageal cancer 60 adnexal mass 60 Peripheral arterial disease 60 radioiodine therapy 60 benign breast 60 foodborne infections 60 gastrointestinal GI cancers 60 adjuvant radiation 60 F FDG PET 60 fecal occult blood 60 clinically detectable 60 idiopathic myelofibrosis 60 histological subtype 60 hematopoietic malignancies 60 RAS mutations 59 C. trachomatis 59 respiratory viral infections 59 biochemical recurrence 59 diabetic kidney 59 acute rheumatic fever 59 thyrotropin levels 59 latent TB infection 59 BARACLUDE ® 59 pT2 59 penetrance 59 Uterine cancer 59 lung cancer 59 Chlamydia infections 59 abnormal cytology 59 cardiovascular disease CVD 59 lymphomas 59 Androgenetic Alopecia 59 neovascular AMD 59 gastrointestinal stromal tumor 59 late onset hypogonadism 59 intensive statin therapy 59 Carcinoma 59 specific antigen PSA 59 recurrent glioblastoma multiforme GBM 59 adenomas 59 EGFR mutations 59 PSADT 59 lung pancreatic 59 thyroid cancers 59 neuroblastomas 59 androgen deficiency 59 BCG refractory 59 CTAP# Capsules 59 rheumatic diseases 59 histologic subtypes 59 gefitinib Iressa 59 contralateral breast cancer 59 curative resection 59 Chlamydia trachomatis 59 premalignant 59 fragility fractures 59 medically inoperable 59 Systemic Lupus Erythematosus SLE 59 lipid abnormalities 59 breast cancer susceptibility genes 59 neovascular diseases 59 thromboembolic events 59 perioperative mortality 59 Retinopathy 59 breast pancreatic 59 cytoreductive surgery 59 tumor recurrence 59 LHRH receptor positive 59 essential thrombocythemia 59 malignancy 59 spiral computed tomography 59 recurrent metastatic 59 myeloproliferative diseases 59 familial hypercholesterolemia 59 Menopausal hormone therapy 59 hyperhomocysteinemia 59 mycosis fungoides 59 non Hodgkin lymphomas 59 Hydroxyurea 59 interstitial pneumonia 59 intestinal polyps 59 Chronic Lymphocytic Leukemia 59 varices 59 terlipressin 59 MammaPrint R 59 diagnostic modality 59 aneuploidy screening 59 colorectal cancer screening 59 recurrent glioblastoma multiforme 59 Squamous cell 59 hemorrhagic complications 59 adenocarcinoma 59 metastatic cancer 59 frequently benign tumor 59 metastatic bladder 59 cardiovascular disease 59 hypereosinophilic syndrome 59 mucinous 59 axillary dissection 59 Leber congenital amaurosis LCA 59 Hyperlipidemia 59 malignant lymphomas 59 mammographically 59 breast cancer 59 venous thromboembolic disease 59 thyrotropin 59 malignant growths 59 nonproliferative 59 cancerous enlargement 59 intracranial hemorrhage ICH 59 bacterial prostatitis 59 N. gonorrhoeae 59 cirrhosis liver failure 59 myeloproliferative disorders 59 Cytogenetic 59 ankylosing spondylitis AS 59 macroalbuminuria 59 squamous cell cancers 59 postoperative mortality 59 hepatitis C HCV 59 atherosclerotic disease 59 congenital CMV infection 59 Candidiasis 59 CABG surgeries 59 multimodality therapy 59 systemic lupus erythematosus 59 EBV infection 59 Cervista HPV 59 CC genotype 59 H. pylori eradication 59 PHPT 59 radical prostatectomy RP 59 Basal cell 59 hypoparathyroidism 59 macrovascular events 59 acute aortic dissection 59 LRP5 59 Screening Trial DMIST 59 polyp detection 59 lung colorectal 59 urine cytology 59 Follicular Lymphoma 59 Sezary syndrome 59 hypertensives 59 serologic 59 Colon polyps 59 neoplastic diseases 59 #F FDG PET 59 cervical lymph nodes 59 glycated hemoglobin levels 59 cytologic 59 NNRTI resistance 59 familial adenomatous polyposis 59 breast cancer metastasis 59 BRCA1 mutation carriers 59 TT genotype 59 chromosomal abnormalities 59 CIN2 59 de novo AML 59 SSc 59 urinary bladder cancer 59 metastatic disease 59 peripheral arterial disease 59 cisplatin resistant 59 TTR amyloidosis 59 cervical precancer 59 Vitamin B# deficiency 59 HBeAg negative 59 prognostic indicator 59 latent tuberculosis TB 59 pre cancerous lesions 59 fetal malformations 59 arterial calcification 59 CYP#D# gene 59 immunosuppressive therapies 59 mammographic density 59 prostate colon 59 vesicoureteral reflux VUR 59 vWD 59 lung tumors 59 Chlamydia trachomatis infection 59 thrombocytopenic 59 cervical cytology 59 hypovitaminosis D 59 gonococcal infection 59 NMIBC 59 invasive lobular carcinoma 59 molecular biomarkers 59 basal cell cancers 59 ductal lobular 59 Velcade bortezomib 59 gonococcal 59 recurrent tonsillitis 59 KRAS oncogene 59 solar keratosis 59 TP# mutations 59 colon rectal 59 cervical dysplasia 59 ALK mutations 59 colorectal polyp 59 undergoing radical prostatectomy 59 H pylori 59 idiopathic pulmonary fibrosis IPF 59 APOL1 59 metastatic lesions 59 oesophageal 59 Prehypertension 59 locoregional 59 SRBD 59 dentinal hypersensitivity 59 post thrombotic syndrome 59 BRCA1 BRCA2 59 haematologic 59 hyperplasia BPH 59 Recombinant interferon alpha 59 CHEK2 59 lung resections 59 axillary lymph nodes 59 Ectopic pregnancy 59 Critical Limb Ischemia CLI 59 carcinoid tumor 59 B7 H3 59 subclinical atherosclerosis 59 European Randomized Study 59 hepatic steatosis 58 anti JCV antibodies 58 Colorectal cancer CRC 58 astrocytomas 58 dose ionizing radiation 58 androgen deprivation 58 Metastatic breast cancer 58 myelomas 58 Iron deficiency anemia 58 malignant ascites 58 PNH patients 58 FGFR2 gene 58 PSA nadir 58 platelet reactivity 58 B Cell Lymphoma 58 congenital toxoplasmosis 58 microvascular disease 58 latent celiac disease 58 metastatic kidney 58 abnormal pap smears 58 complete cytogenetic response 58 Clostridium difficile infections 58 interstitial cystitis IC 58 Anthracycline 58 cervical cancer 58 Testicular cancer 58 pheochromocytoma 58 Irritable Bowel Syndrome IBS 58 unexplained mental retardation 58 castrate resistant prostate cancer 58 HER2 gene 58 syndromic 58 hydroxyvitamin D levels 58 hepatectomy 58 Chlamydia infection 58 colorectal carcinogenesis 58 Acute lymphoblastic leukemia 58 Metastatic Prostate Cancer 58 carcinomatosis 58 leukemia AML 58 abdominal adiposity 58 T2D 58 KIF6 gene 58 microvascular complications 58 atherogenic dyslipidemia 58 lymphoproliferative disorders 58 ovarian malignancy 58 elevated LDH 58 pancreatic prostate 58 colorectal liver metastases 58 systolic dysfunction 58 deCODE BreastCancer 58 SJIA 58 liver cancer 58 monoclonal gammopathy 58 serum prostate 58 inflammatory rheumatic 58 precancerous tumors 58 prostate cancer CRPC 58 adjuvant therapy 58 Bronchiectasis 58 neoplastic 58 Barrett esophagus BE 58 obstructive coronary artery 58 monogenic 58 Metastatic 58 pathologic myopia 58 incidentalomas 58 Bladder cancer 58 Krabbe Disease 58 hepatitis C genotype 58 chronic hepatitis cirrhosis 58 relapsed MM 58 extracolonic findings 58 endocrine therapies 58 dyslipidaemia 58 Idiopathic pulmonary fibrosis 58 Hurler syndrome 58 lymphadenectomy 58 Carcinoid tumors 58 K ras mutations 58 Medullary thyroid cancer 58 LNG IUS 58 Neoplasms 58 primary biliary cirrhosis 58 transplantation HCT 58 guaiac 58 cranial irradiation 58 GSTP1 58 lymph node metastasis 58 familial adenomatous polyposis FAP 58 vesicoureteral reflux 58 metastatic colorectal cancer 58 multiple myeloma MM 58 dysplastic lesions 58 vascular disease 58 lymphatic tissue 58 methylation markers 58 Chronic myeloid leukemia 58 leiomyoma 58 lung adenocarcinomas 58 systemic amyloidosis 58 intra abdominal abscess 58 myelofibrosis MF 58 hematologic disorders 58 POAG 58 breast tumors 58 completely resected 58 retrospective cohort 58 Severe Primary IGFD 58 pheochromocytomas 58 alcoholic fatty liver 58 familial ALS 58 Neisseria gonorrhoeae 58 deferiprone 58 HER2 positive 58 gene BRCA2 58 TPMT 58 elevated CRP 58 Warfarin Coumadin 58 Basal cell carcinoma 58 GABHS 58 TGFBR1 * 6A 58 Epigenomics proprietary 58 ToGA 58 bowel polyps 58 2 diabetes T2D 58 MetS 58 thromboembolic complications 58 IV NSCLC 58 cytological 58 urological cancers 58 neuropsychiatric symptoms 58 telomere lengths 58 neovascular 58 Thyroid disorders 58 IPAH 58 ependymomas 58 Chronic myeloid leukemia CML 58 immunochemical 58 Surgical resection 58 facial clefts 58 varicocele 58 Pseudomonas aeruginosa infections 58 Renal Cell Carcinoma 58 onset diabetes mellitus 58 ReA 58 nonfasting triglyceride levels 58 cervical precancers 58 KRAS mutations occur 58 Chronic Lymphocytic Leukemia CLL 58 postmenopausal hormone 58 decompensated liver disease 58 pancreatic ovarian 58 benign polyps 58 IgA deficiency 58 immunological diseases 58 Folate deficiency 58 Periodontitis 58 aneuploidy 58 thromboembolism 58 Periodontal disease 58 β blockers 58 orchitis 58 JMML 58 artery stenosis 58 #q#.# [001] 58 pelvic malignancies 58 carcinoma HNSCC 58 neoplasia PIN 58 breast cervical 58 locoregional recurrence 58 malignant transformation 58 Soft Tissue Sarcoma 58 lupus anticoagulant 58 pediatric acute lymphoblastic 58 poor metabolizers 58 non alcoholic steatohepatitis 58 Benign prostatic hyperplasia BPH 58 femoral neck fractures 58 Natalizumab 58 malignant melanoma 58 imatinib Gleevec 58 Barrett Esophagus 58 nephrogenic 58 proton MR spectroscopy 58 Circulating tumor cells 58 pancreatic carcinoma 58 ccRCC 58 hyperplastic 58 HPV subtypes 58 NOMID 58 complement inhibitor eculizumab 58 PIK3CA 58 Fatty Liver Disease 58 mitochondrial toxicity 58 iron overload 58 asymptomatic bacteriuria 58 malignant nodules 58 MSH2 58 colonoscopy sigmoidoscopy 58 DCIS lesions 58 Non Alcoholic Steatohepatitis 58 atherothrombosis 58 post surgical adhesions 58 cerebral vasospasm 58 Premature Ovarian Failure 58 ano genital warts 58 Chronic Myelogenous Leukemia CML 58 antitumor effect 58 dasatinib Sprycel 58 gynecologic cancer 58 Clusterin 58 Cervista HPV HR 58 colon tumors 58 Epidermal Growth Factor Receptor 58 receptor tyrosine kinase inhibitor 58 genital ulcers 58 benign proliferative breast 58 recurrent VTE 58 BRCA carriers 58 Thromboembolism 58 LHON 58 sentinel lymph node biopsy 58 BRCA2 gene mutation 58 chronic rhinosinusitis CRS 58 chemoradiotherapy 58 Statin therapy 58 Venous thromboembolism 58 type 1diabetes 58 perinatal mortality 58 GH deficiency 58 Nonalcoholic Fatty Liver Disease 58 laryngeal cancer 58 ThinPrep Pap Test 58 albumin excretion rate 58 pancreatic neuroendocrine tumors 58 PCA3 scores 58 Colorectal 58 prostate carcinomas 58 CSF biomarkers 58 cancerous polyps 58 stage IIIB 58 serum PSA 58 motor neuron degeneration 58 VEGF expression 58 diabetic retinopathy 58 Endometrial 58 hereditary antithrombin deficiency 58 metastatic RCC 58 Hemoccult II 58 geographic atrophy 58 NPM1 58 rs# [002] 58 androgenic alopecia 58 Melasma 58 benign prostatic hypertrophy BPH 58 Erythropoietic therapies may 58 perinatal outcomes 58 endoscopic ultrasonography 58 invasive fungal infections 58 cytoreductive nephrectomy 58 pancreatic cysts 58 metaplasia 58 liver resection 58 Chronic HCV 58 lung metastases 58 hyperphenylalaninemia HPA due 58 myocardial ischaemia 58 hepatic toxicity 58 genetic syndromes 58 infective endocarditis 58 MYCN amplification 58 penile cancers 58 gonococcal infections 58 autonomic dysfunction 58 SEER database 58 herpes zoster shingles 58 HbA1C 58 HBV vaccination 58 Hematologic 58 pre malignant lesions 58 Arch Intern Med 58 psoriatic arthritis PsA 58 paroxysmal nocturnal hemoglobinuria 57 mtDNA mutations 57 NMP# 57 Gleevec resistant 57 abnormal mammograms 57 non metastatic osteosarcoma 57 Lymph node 57 extracranial